5,7-dimethyl[1,2,4]triazolo[1,5-a]pyrimidin-2-amine, 95.0%, 1g

(4s)-4-Isopropyl-5,5-diphenyl-3-[(2r,3s)-4,4,4-trifluoro-3-hydroxy-2,3-dimethyl-butanoyl]oxazolidin-2-one, 98%, 1g

Symbole d'avertissement selon ISO 7010 Étiquette individuelle, Rayonnement non ionisant, Longueur de côté 200 mm, 1 pièce

6,10-Dioxaspiro[4.5]decane-7,9-dione, 95.0%, 25g

4,4'-(1,2-Diphenylethene-1,2-diyl)dianiline, 98%, 5g

tert-Butyl (5-(trifluoromethyl)pyridin-3-yl)carbamate, 95.0%, 10g

2-(2-HYDROXYPHENYL)-[1,2,4]TRIAZOLO[1,5-A]PYRIDINE-8-CARBOXYLIC ACID, 95.0%, 250mg

N-Methyl-N'-pentyl ethylenediamine, 96.0%, 250mg

2-Methyl-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazine, 97%, 50mg

5-(Methoxymethyl)-1-methyl-1H-pyrazole-3-carboxylic acid, 100mg

Ethyl 5-ethoxy-1H-indole-2-carboxylate, 97%, 5g

tert-Butyl 3-(4-nitro-1H-pyrazol-1-yl)pyrrolidine-1-carboxylate, 97%, 2.5g

trans-3,5-Difluorocinnamic Acid>98.0%(GC)(T)5g